18
Participants
Start Date
May 31, 2017
Primary Completion Date
November 21, 2019
Study Completion Date
May 24, 2023
Ferumoxytol
Given IV
Irinotecan Sucrosofate
Given IV
Laboratory Biomarker Analysis
Correlative studies
Magnetic Resonance Imaging
Undergo MRI
Veliparib
Given PO
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
National Institutes of Health Clinical Center, Bethesda
NCI - Center for Cancer Research, Bethesda
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Cleveland Clinic Foundation, Cleveland
Mayo Clinic in Rochester, Rochester
National Cancer Institute (NCI)
NIH